12:00 AM
 | 
Feb 22, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ThGRF 1-44: Phae Ib

TH said that ThGRF 1-44 significantly increased levels of insulin-like growth factor-1 ( IGF-1) versus placebo in its Phase Ib study in 39 volunteers...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >